[HTML][HTML] ATR inhibitor AZD6738 enhances the antitumor activity of radiotherapy and immune checkpoint inhibitors by potentiating the tumor immune microenvironment …
H Sheng, Y Huang, Y Xiao, Z Zhu, M Shen… - … for immunotherapy of …, 2020 - ncbi.nlm.nih.gov
Background Radioimmunotherapy has a promising antitumor effect in hepatocellular
carcinoma (HCC), depending on the regulatory effect of radiotherapy on tumor immune …
carcinoma (HCC), depending on the regulatory effect of radiotherapy on tumor immune …
[HTML][HTML] Safety of PD-1/PD-L1 inhibitors combined with palliative radiotherapy and anti-angiogenic therapy in advanced hepatocellular carcinoma
L Zhong, D Wu, W Peng, H Sheng, Y Xiao… - Frontiers in …, 2021 - frontiersin.org
Background Previous studies have explored cancer immunotherapy with radiotherapy or
anti-angiogenic therapy, but no trials have reported a triple therapy approach. This study …
anti-angiogenic therapy, but no trials have reported a triple therapy approach. This study …
[HTML][HTML] Wnt/β-catenin inhibitor ICG-001 enhances the antitumor efficacy of radiotherapy by increasing radiation-induced DNA damage and improving tumor immune …
Y Huang, H Sheng, Y Xiao, W Hu, Z Zhang… - Radiotherapy and …, 2021 - Elsevier
Background and purpose Radiotherapy (RT) has a promising anti-tumor effect depending
on its effects on both cancer cells and tumor immune microenvironment (TIME). As one of …
on its effects on both cancer cells and tumor immune microenvironment (TIME). As one of …
[HTML][HTML] Investigating private sectors' behavioral intention to participate in PPP projects: An empirical examination based on the theory of planned behavior
The active involvement of private sectors in Public-Private-Partnership (PPP) projects is
critical for sustainable development of the PPP mode. While there have been many studies …
critical for sustainable development of the PPP mode. While there have been many studies …
Single-cell Transcriptomic Analysis Reveals an Immunosuppressive Network Between POSTN CAFs and ACKR1 ECs in TKI-resistant Lung Cancer
Z Wang, N Yan, H Sheng, Y Xiao… - Cancer Genomics & …, 2024 - cgp.iiarjournals.org
Abstract Background/Aim: Tyrosine kinase inhibitor (TKI) therapy, a principal treatment for
advanced non-small cell lung cancer (NSCLC), frequently encounters the development of …
advanced non-small cell lung cancer (NSCLC), frequently encounters the development of …
[HTML][HTML] Upregulated long non‑coding RNA LincIN promotes tumor progression via the regulation of nuclear factor 90/microRNA‑7/HOXB13 in esophageal squamous …
Z Tan, P Zhou, Z Zhu, Y Wang… - International …, 2021 - spandidos-publications.com
Long non‑coding RNA LincIN has been reported to be overexpressed and to be involved in
the metastasis of breast cancer. However, the expression and role of LincIN in esophageal …
the metastasis of breast cancer. However, the expression and role of LincIN in esophageal …
Mapping Atlas of Shenzhen-Urban Villages
M van Oostrum, J Liu, Y Li, R Hoek, Y Yang, Z He… - 2017 - repository.tudelft.nl
This publication is in response to the call of 2017 Bi-City Biennale of Urbanism\Architecture
(Shenzhen)(UABB)“Cities, Grow in Difference”, from the perspective of urbanism: the …
(Shenzhen)(UABB)“Cities, Grow in Difference”, from the perspective of urbanism: the …
[PDF][PDF] Wnt/β-catenin Inhibitor ICG-001 Enhances the Antitumor E cacy of Radiotherapy by Increasing Radiation-induced DNA Damage and Improving Tumor Immune …
Y Huang, H Sheng, Y Xiao, Z Zhang, Y Chen, Z Zhu… - pdfs.semanticscholar.org
Background: Radiotherapy has a promising anti-tumor effect in hepatocellular carcinoma
(HCC), depending on the its regulatory effects on both cancer cells and tumor immune …
(HCC), depending on the its regulatory effects on both cancer cells and tumor immune …